Topic Paragraphs
Featured Topics
FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Jan 23
FDA informs health care providers, facilities and patients about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers
Jan 23
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jan 22
Lipari Foods Issues Voluntary Recall Expansion on Additional Sandwiches Due to Potential Contamination of Listeria Monocytogenes
Food & Beverages
Jan 21
Savannah Food Company, Inc. Voluntarily Recalls Cornbread Dressing and Bread Stuffing Products Due to Possible Health Risk
Food & Beverages
Jan 21
ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
Dietary Supplements
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Shedding More Light on Sunscreen Absorption
New research adds to our understanding of sunscreens
FDA Harnesses Technology and Collaboration to Support Rare Disease Product Development
Announcing an Orphan Drug Technology Modernization effort and the 2020 FDA Rare Disease Day meeting
Outbreaks Emphasize the Importance of Implementing Produce Safety Standards
Our commitment to advancing produce safety is unwavering.
Recently Published Guidances
Jan 23
Clinical Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry
Drugs
Jan 23
In Vitro Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry
Drugs
Jan 23
Assessing User Fees Under the Biosimilar User Fee Amendments of 2017 Guidance for Industry
Drugs